Monthly Performance
Quarterly Performance
As of 5/31/2024MonthYTD1 Year3 Year15 Year110 Year1Since Inception1,2

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX)




MSCI ACWI Minimum Volatility (USD) Index

As of 3/31/2024QuarterYTD1 Year3 Year15 Year110 Year1Since Inception1,2

Aspiriant Risk-Managed Equity Allocation Fund (RMEAX)




MSCI ACWI Minimum Volatility (USD) Index


1 Annualized.

2 Fund inception date 4/4/2013.

The performance data quoted represents past performance and is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance information quoted. To obtain performance information current to the most recent month-end, please call 1.877.997.9971.

The gross and net expense ratios are 0.93% and 0.79%, respectively.*

The adviser has contractually agreed to waive its advisory fee from 0.24% to 0.16% and administrative services fee from 0.10% to 0.04% through July 31, 2024. Each arrangement may be terminated only by Aspiriant Trust’s Board of Trustees.

The MSCI ACWI is a free float-adjusted market capitalization weighted index that is designed to measure the equity performance of developed and emerging markets. The MSCI ACWI covers the Large and Mid-Capitalization securities as defined by MSCI. Indices are unmanaged and have no fees. It is not possible to invest directly in an index.

The MSCI ACWI Minimum Volatility (USD) Index is composed of developed and emerging market equities that, in the aggregate, have lower volatility characteristics relative to the broader developed and emerging equity markets. Indices are unmanaged and have no fees. It is not possible to invest directly in an index.

*Effective 8/1/2023.

Please consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. The prospectus that contains this and other information about the Fund is available by calling 1.877.997.9971 and should be read carefully prior to investing.

An investment in the Fund is subject to risks, and you could lose money on your investment in the Fund. The principal risks of investing in the Fund include, but are not limited to, asset allocation, investing in smaller companies with limited resources and the use of predictive models. Low volatility and quality investing may go in and out of favor which may cause the Fund to sometimes underperform other equity funds. The Fund may invest in illiquid securities, which may or may not be sold or disposed of in the ordinary course of business. Foreign securities, including depositary receipts, have additional risks including currency rate changes, political and economic instability, less regulation and market liquidity. Investments in emerging markets involve even greater risks. The adviser and sub-advisers may be unable to construct the Fund’s investment portfolio such that the intended federal tax implications, when making investment decisions with respect to individual securities, are achieved. As a result of its investments in underlying funds, the Fund is exposed to the principal risks of underlying funds. These risks include counterparty, derivatives, focused investment, large shareholder, leverage and short sale risks. Further information about these and other risks may be found in the prospectus.

Aspiriant Risk-Managed Equity Allocation Fund is distributed by UMB Distribution Services, LLC. Check the background of this firm on FINRA’s BrokerCheck

Quick Facts

Ticker Symbol




Inception Date


Fund Assets

$1.36 Billion
(as of 5/31/2024)

Number of Equity Holdings

176 (as of 3/31/2024)


Distributed Annually